ARCADIS, Chelmsford, MA 01824, USA.
Regul Toxicol Pharmacol. 2010 Jul-Aug;57(2-3):168-80. doi: 10.1016/j.yrtph.2010.02.004. Epub 2010 Feb 13.
Several naphthalene Unit Risk Factors (URFs) were proposed by the US Environmental Protection Agency in 2004 using data on the development of olfactory epithelial neuroblastomas and nasal respiratory epithelial adenomas in rats, but these URFs may be inappropriate and unnecessarily conservative for estimating human cancer risks. The purpose of the present exercise was to perform a screening-level population risk assessment of the US population to compare the observed number of naphthalene-induced nasal tumors in the US to the number that would be predicted if the URFs for naphthalene were as proposed. Nine scenarios were evaluated to represent the range of exposures individuals have typically experienced. Results indicate that the total predicted burden of naphthalene-induced nasal tumors per year in the US (65,905 rare nasal tumors, of which 29,121 are olfactory epithelial neuroblastomas) is much greater than the number of these tumors actually observed per year (910 total nasal tumors, of which 66 are olfactory neuroblastomas) over the period 1973-2006. This suggests that using rat nasal tumor data to derive a naphthalene URF for humans should be re-evaluated.
美国环保署在 2004 年提出了几个萘单位风险因素(URF),这些因素是基于大鼠嗅上皮神经母细胞瘤和鼻呼吸上皮腺瘤的发展数据得出的,但这些 URF 对于估计人类癌症风险可能不适用且过于保守。本研究的目的是对美国人群进行筛查水平的人群风险评估,将美国观察到的萘诱导的鼻肿瘤数量与如果按照萘 URF 预测的数量进行比较。评估了九个场景来代表个体通常经历的暴露范围。结果表明,在 1973-2006 年期间,美国每年萘诱导的鼻肿瘤的总预测负担(65905 例罕见的鼻肿瘤,其中 29121 例为嗅上皮神经母细胞瘤)远高于每年实际观察到的这些肿瘤的数量(910 例总鼻肿瘤,其中 66 例为嗅神经母细胞瘤)。这表明,使用大鼠鼻肿瘤数据来推导人类萘 URF 应该重新评估。